New pills for poor people? Empirical evidence after GATT
New pills for poor people? Empirical evidence after GATT
复制标题
DOI：
10.1016/s0305-750x(00)00099-1
复制
发表时间：
2001-02-01
影响因子：
6.9
通讯作者：
Cockburn, IM
中科院分区：
文献类型：
--
作者：
Lanjouw, JO;Cockburn, IM
随着许多发展中国家对新药实行专利保护，对药品创新的保护正在大大扩大。知识产权的这种变化可能导致更多的药物研究，以满足发展中国家的需求。我们使用来自印度的新调查数据、访谈结果以及从各种统计来源构建的研发（R&D）措施，以确定研究分配给发展中国家市场特定产品的趋势。有一些尽管有限的证据表明，在1980年代中期至后期有所增加，而在1990年代似乎已趋于平稳。这幅图提供了一个“基线”，可以用来比较未来研究活动的模式。2001爱思唯尔科学有限公司版权所有。
The protection of pharmaceutical innovations is being dramatically extended as much of the developing world introduces patent protection for new drug products. This change in intellectual property rights may lead to more research on drugs to address developing country needs. We use new survey data from India, the results of interviews, and measures of research and development (R&D) constructed from a variety of statistical sources to determine trends in the allocation of research to products specific to developing country markets. There is some, although limited, evidence of an increase in the mid- to late 1980s which appears to have leveled off in the 1990s. The picture presented provides a "baseline" against which future patterns in research activity can he compared. (C) 2001 Elsevier Science Ltd. All rights reserved.